Asthma Patients Warned About Higher Risk of Severe Attacks Due to Excessive Use of Blue Inhalers
This announcement serves as a reminder regarding updates to product information and the guidance from the National Institute for Health and Care Excellence (NICE) pertaining to short-acting beta 2 agonists (SABAs), such as salbutamol and terbutaline, which are utilized to alleviate sudden asthma symptoms including chest tightness, wheezing, coughing, and breathlessness. Patients should continue to …